2 Comments
⭠ Return to thread

Thanks. I really appreciate the link, it's never good to make false claims. I noticed that the date on the Time magazine article was Feb. 2021. That would put it early in the roll out campaign. Actually, that still leaves me rather suspicious: Pfizer said “As we made more commercial-scale lots, we took those lots and put them in our stability program and gathered enough data on the [regular] freezer temperatures" (from the Time article).

How'd they manage that and FDA approval so quickly?

It's also contingent on Pfizer's quality control. How has their quality control worked out?

Expand full comment

I looked at the FDA's press release from their website also.

Expand full comment